B-CELL LYMPHOMA RECURRENT
Clinical trials for B-CELL LYMPHOMA RECURRENT explained in plain language.
Never miss a new study
Get alerted when new B-CELL LYMPHOMA RECURRENT trials appear
Sign up with your email to follow new studies for B-CELL LYMPHOMA RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for hard-to-treat brain lymphoma: drug combo enters human trials
Disease control Recruiting nowThis study tests a new drug, selinexor, added to standard chemotherapy for people with a type of blood cancer (B-cell lymphoma) that has come back or not responded to treatment and has spread to the brain. The goal is to see if the combination is safe and works better than curren…
Matched conditions: B-CELL LYMPHOMA RECURRENT
Phase: PHASE1, PHASE2 • Sponsor: Samsung Medical Center • Aim: Disease control
Last updated Jun 15, 2026 19:05 UTC
-
New Gene-Modified immune cells take on Hard-to-Treat lymphoma
Disease control Recruiting nowThis trial tests a new treatment called TranspoCART19 for people with B-cell lymphoma that has come back or not responded to standard therapy. The treatment uses a patient's own immune cells, which are modified in a lab to better recognize and attack cancer cells. The study aims …
Matched conditions: B-CELL LYMPHOMA RECURRENT
Phase: PHASE1, PHASE2 • Sponsor: Instituto de Investigación Biomédica de Salamanca • Aim: Disease control
Last updated Jun 15, 2026 19:01 UTC
-
New CAR-T therapy trial targets tough blood cancers
Disease control Recruiting nowThis early-phase trial tests a personalized treatment where a patient's own immune cells are genetically modified to recognize and attack cancer cells. It is for children and adults with certain blood cancers (like leukemia or lymphoma) that have not responded to standard treatme…
Matched conditions: B-CELL LYMPHOMA RECURRENT
Phase: PHASE1 • Sponsor: Nelson Hamerschlak • Aim: Disease control
Last updated Jun 15, 2026 18:56 UTC